U.S. Nursing Homes Reducing Use of Antipsychotic Drugs

TUESDAY, Aug. 27 (HealthDay News) -- A year-old nationwide effort to prevent the unnecessary use of antipsychotic medications in U.S. nursing homes already seems to be working, public health officials report, as facilities begin to opt for patient-centered approaches over drugs to treat dementia and other related complications.

So far, the program has seen more than a 9 percent drop in the national use of antipsychotics among long-term nursing-home residents, when comparing the period of January to March 2013 with October to December 2011.

The National Partnership to Improve Dementia Care was launched in 2012 by the U.S. Centers for Medicare & Medicaid Services (CMS). At issue: the broad over-prescription of antipsychotics among the nation's roughly 1.5 million nursing-home residents.

"This important partnership to improve dementia care in nursing homes is yielding results," Dr. Patrick Conway, CMS chief medical officer and director of the Center for Clinical Standards and Quality, said in an agency news release.

"We will continue to work with clinicians, caregivers and communities to improve care and eliminate harm for people living with dementia," Conway added.

As recently as 2010, more than 17 percent of nursing-home patients were being given daily doses of antipsychotic medications that were above recommended levels, according to the news release.

With that in mind, the campaign set out to provide enhanced dementia care training for nursing-home staff and statewide nursing-home assessors, by outlining alternative treatment options and making relevant antipsychotic medication information more easily accessible online on its Nursing Home Compare website.

The information provided is a collection of best-practices information gathered from a coalition of medical and quality-improvement experts, government agencies, consumer and patient advocates, and long-term-care providers.

The campaign's goal is to lower antipsychotic drug use by 15 percent by the end of this year.

To date, 11 states have realized -- or even exceeded -- this objective: Alabama, Delaware, Georgia, Kentucky, Maine, North Carolina, Oklahoma, Rhode Island, South Carolina, Tennessee and Vermont.

As a result, an estimated 30,000 fewer nursing-home patients are on antipsychotics today than would have been prior to the launch of the CMS information program.

More information

For more on the CMS partnership campaign to improve dementia care, visit Advancing Excellence in American Nursing Homes.

SOURCE: U.S. Centers for Medicare & Medicaid Services, news release, Aug. 27, 2013

Related Articles

Learn More About Sharp
Sharp HealthCare is San Diego's health care leader with seven hospitals, two medical groups and a health plan. Learn more about our San Diego hospitals, choose a Sharp-affiliated San Diego doctor or browse our comprehensive medical services.

Health News is provided as a service to Sharp Web site users by HealthDay. Sharp HealthCare nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please read the Terms of Use for more information.